EP

Epinoma

YC S21

San Francisco, US · Founded 2020 · 8 employees · 3 known investors

epinoma.com ↗

Epinoma develops EpiAmp, a methyl-preserving amplification technology to analyze epigenetic changes and methylation patterns for applications in disease detection, drug development, and patient stratification. The company serves research institutions, pharmaceutical companies, and clinical diagnostic organizations in the biotech and healthcare sectors.

Founders & leadership· Y Combinator alumni (S21)

Varun GovilinFounder

Zhijian LiinFounder

Investors · 3

Y

Y CombinatorSan Francisco · $500K – $500K

SE

SeaX Venturesreported

SE

SeedToBreportedSuwanee · $500K – $1.5M